Allena Pharmaceuticals Inc (NASDAQ:ALNA) – Equities researchers at B. Riley issued their FY2023 earnings estimates for Allena Pharmaceuticals in a research report issued to clients and investors on Friday, July 26th, according to Zacks Investment Research. B. Riley analyst M. Mamtani expects that the company will post earnings per share of ($0.37) for the year.

Brink’s (NYSE:BCO) – Analysts at Imperial Capital cut their FY2019 earnings estimates for Brink’s in a research report issued on Thursday, July 25th, according to Zacks Investment Research. Imperial Capital analyst J. Kessler now expects that the business services provider will post earnings per share of $4.27 for the year, down from their prior forecast of $4.30. Imperial Capital currently has a “Outperform” rating and a $105.00 target price on the stock. Imperial Capital also issued estimates for Brink’s’ Q4 2019 earnings at $1.56 EPS, Q1 2020 earnings at $1.00 EPS, Q2 2020 earnings at $1.02 EPS, Q3 2020 earnings at $1.37 EPS and FY2020 earnings at $5.09 EPS.

Century Aluminum Co (NASDAQ:CENX) – Equities research analysts at B. Riley upped their FY2021 EPS estimates for Century Aluminum in a research note issued on Monday, August 5th, Zacks Investment Research reports. B. Riley analyst L. Pipes now anticipates that the industrial products company will earn $2.07 per share for the year, up from their prior forecast of $1.99.

MarineMax Inc (NYSE:HZO) – Analysts at Wedbush dropped their FY2019 earnings per share (EPS) estimates for MarineMax in a research note issued to investors on Friday, July 26th, Zacks Investment Research reports. Wedbush analyst J. Hardiman now expects that the specialty retailer will earn $1.70 per share for the year, down from their prior forecast of $1.73. Wedbush also issued estimates for MarineMax’s Q4 2019 earnings at $0.42 EPS and FY2020 earnings at $1.76 EPS.

Equity Residential (NYSE:EQR) was the recipient of a large drop in short interest during the month of July. As of July 15th, there was short interest totalling 4,679,900 shares, a drop of 7.8% from the June 15th total of 5,074,900 shares. Based on an average trading volume of 1,100,000 shares, the days-to-cover ratio is currently 4.3 days. Approximately 1.3% of the company’s shares are sold short.

Qualys Inc (NASDAQ:QLYS) – Analysts at KeyCorp boosted their Q3 2019 EPS estimates for shares of Qualys in a research report issued on Wednesday, July 31st, according to Zacks Investment Research. KeyCorp analyst R. Owens now expects that the software maker will post earnings of $0.39 per share for the quarter, up from their prior forecast of $0.34.

Amedisys Inc (NASDAQ:AMED) – Equities researchers at Jefferies Financial Group boosted their FY2020 earnings estimates for shares of Amedisys in a report issued on Wednesday, July 31st, according to Zacks Investment Research. Jefferies Financial Group analyst B. Tanquilut now forecasts that the health services provider will earn $4.95 per share for the year, up from their prior forecast of $4.85. Jefferies Financial Group has a “Buy” rating and a $150.00 price objective on the stock.

Equity Investment Corp lowered its stake in PepsiCo, Inc. (NASDAQ:PEP) by 23.2% during the 2nd quarter, HoldingsChannel reports. The firm owned 615,436 shares of the company’s stock after selling 186,271 shares during the period. PepsiCo comprises 2.8% of Equity Investment Corp’s holdings, making the stock its 16th largest position. Equity Investment Corp’s holdings in PepsiCo were worth $80,702,000 as of its most recent SEC filing.

Clearwater Paper Corp (NYSE:CLW) – Stock analysts at DA Davidson raised their Q3 2019 EPS estimates for shares of Clearwater Paper in a report released on Thursday, August 1st, Zacks Investment Research reports. DA Davidson analyst S. Chercover now anticipates that the basic materials company will earn ($0.29) per share for the quarter, up from their prior forecast of ($0.50). DA Davidson also issued estimates for Clearwater Paper’s FY2019 earnings at ($0.07) EPS and FY2020 earnings at $1.25 EPS.

Exelixis, Inc. (NASDAQ:EXEL) – Research analysts at Oppenheimer reduced their Q3 2019 earnings per share estimates for Exelixis in a report released on Wednesday, July 31st, Zacks Investment Research reports. Oppenheimer analyst S. Tuerkcan now anticipates that the biotechnology company will post earnings of $0.16 per share for the quarter, down from their prior forecast of $0.17. Oppenheimer also issued estimates for Exelixis’ Q4 2019 earnings at $0.16 EPS, FY2019 earnings at $0.82 EPS, FY2020 earnings at $0.94 EPS, FY2021 earnings at $0.97 EPS and FY2023 earnings at $1.63 EPS.